The iStopMM research project is about to get started in Iceland. It is supported through the IMF’s Black Swan Research Initiative® and literally will include Screening, Treating Or Preventing myeloma. Beginning in October 2016, approximately 140,000 people over 40 in Iceland will be screened with SPEP (serum protein electrophoresis), UPEP (urine protein electrophoresis), and Freelite tests to see if they have MGUS (monoclonal gammopathy of undetermined significance), smoldering multiple myeloma (SMM), or full-blown multiple myeloma (MM). If they have MGUS or SMM, they will be initially monitored. If they have myeloma, they will be treated.